Incorporating Cryopreservation Evaluations Into the Design of Cell-Based Drug Delivery Systems: An Opinion Paper
An erratum on:
Incorporating cryopreservation evaluations into the design of cell-based drug delivery systems: an opinion paper.
By Ekpo MD, Xie J, Liu X, Onuku R, Boafo GF and Tan S (2022) Front. Immunol. 13:967731.doi: 10.3389/fimmu.2022.967731
Due to a production error, there was a mistake in affiliation two of this article. Instead of “School of Pharmacy, Taipei Medical University, Taipei, Taiwan”, it should be “Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka, Nigeria”.
The publisher sincerely apologizes for this mistake.
The original version of this article has been updated.
Keywords: mesenchymal stem cells, cryopreservation, cryoprotectants, chemotherapy, targeted drug delivery
Citation: Frontiers Production Office (2022) Erratum: Incorporating cryopreservation evaluations into the design of cell-based drug delivery dystems: An opinion paper. Front. Immunol. 13:1020829. doi: 10.3389/fimmu.2022.1020829
Received: 16 August 2022; Accepted: 16 August 2022;
Published: 31 August 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, production.office@frontiersin.org